Turquoise Health
-50%
est. 2Y upside i
Rank
#1288
Sector
Health Care Technology
Est. Liquidity
~3Y
Data Quality
Data: HighTurquoise Health operates in a highly regulated, yet growing, healthcare technology sector with strong tailwinds from price transparency mandates.
Last updated: March 10, 2026
Turquoise Health capitalizes on strong regulatory tailwinds for price transparency and successfully expands its AI-powered contract management solutions, capturing significant market share from legacy systems. Revenue accelerates to over $150M by 2028, justifying a 15x revenue multiple and a valuation exceeding $2.2B, driven by high customer acquisition and retention in a growing, compliance-driven market.
The company maintains its strong position in healthcare price transparency and achieves steady growth in payer-provider contract management. Revenue reaches approximately $60M by 2028, and the company is acquired or IPOs at a valuation of around $640M, reflecting continued market demand for its core offerings and moderate expansion.
Increased competition from well-funded incumbents or specialized startups, coupled with slower-than-expected adoption of contract management solutions, limits growth. Regulatory enforcement softens or becomes commoditized, leading to revenue stagnation at around $40M. A down round or acquisition at a significantly reduced valuation of $128M wipes out most common stock value due to liquidation preferences.
Preference Stack Risk
highFunding Intensity
17%Investors hold $55M in liquidation preferences ahead of common stock, representing 17.2% of the current $320M valuation.
Dilution Risk
moderateAs a Series B company, additional funding rounds are likely before an exit, which will lead to further dilution of existing equity holders.
Secondary Liquidity
activeAn active secondary market exists, as evidenced by the current valuation being derived from secondary transactions and platforms like Forge Global facilitating private share trading.
Questions to Ask at the Interview
Strategic questions based on Turquoise Health's data — designed to show you've done your homework.
- 1
“Given the ongoing evolution of price transparency regulations, how is Turquoise Health strategically positioning itself to adapt to potential changes in mandates or enforcement, particularly concerning the 2026 and 2027 proposed rules?”
- 2
“With large incumbents like Epic and Cerner having adjacent products, what specific product development or partnership strategies are in place to maintain and strengthen Turquoise Health's competitive moat in both price transparency and payer-provider contract management?”
- 3
“Considering the Series B funding and the current secondary market valuation, what is the company's anticipated timeline and strategy for a liquidity event (IPO or acquisition), and how does the preference stack impact potential employee equity outcomes?”
Community
Valuation Sentiment
Our model estimates -50% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.